South Central Banner

South Central Strategic Health Authority

Cancer Drugs Fund

Cancer drug fund

On 1st October 2010 The Department of Health provided an extra £50m in funding nationally to help cancer patients get greater access to cancer drugs their doctors recommend for them.  This fund was known as the Interim Cancer Drugs Fund and the NHS South Central region was allocated £3.4 million up to the end of March 2011.

In April 2011 a £200 million per year Cancer Drugs Fund Scheme was established nationally of which NHS South Central received £9.3 million.

Doctors make applications to the fund on behalf of their patients.  Clinically led panels consider applications individually, putting doctors in charge of deciding how this fund is spent for their patients locally.  Applications for some of the more commonly requested cancer drugs may be approved more quickly without the need to be considered by a clinically led panel.

Each month, a summary will be produced on this website showing the number of applications received, the number of applications approved or declined for clinical reasons and an aggregate cost.

Please note, we will not release information that could lead to the identity of any individual patient, neither will we release details of individual costs for drugs which are likely to be commercially in confidence.

  • Application process
  • Application form
  • Proforma Application Forms
  • Summaries
  • Any Other docs.

Thames Valley Cancer Network administers the fund for NHS South Central.  Here is a link to their website: http://www.tvcn.nhs.uk/

Application Process

To view the Cancer Drug Application Process click here

Downloads

Application forms

Abiraterone pro forma October 2011
Title : Abiraterone pro forma October 2011
Size : 64 kB
Alemtuzumab 1st line p53 deletion October 2011
Title : Alemtuzumab 1st line p53 deletion October 2011
Size : 66 kB
Alemtuzumab relapsed refracory CLL October 2011
Title : Alemtuzumab relapsed refracory CLL October 2011
Size : 67 kB
Bendamustine myeloma October 2011
Title : Bendamustine myeloma October 2011
Size : 67 kB
Bevacizumab 2nd line treatment for colorectal cancer pro forma October 2011
Title : Bevacizumab 2nd line treatment for colorectal cancer pro forma October 2011
Size : 67 kB
Cabazitaxel prostate October 2011
Title : Cabazitaxel prostate October 2011
Size : 63 kB
Cetuximab 2nd3rd line KRAs wild-type relapsed CRC pro forma October 2011
Title : Cetuximab 2nd3rd line KRAs wild-type relapsed CRC pro forma October 2011
Size : 69 kB
Cetuximab head & neck October 2011
Title : Cetuximab head & neck October 2011
Size : 64 kB
Cetuximab KRAs wild-type 1st line CRC pro forma October 2011
Title : Cetuximab KRAs wild-type 1st line CRC pro forma October 2011
Size : 68 kB
Everolimus pNET November 2011
Title : Everolimus pNET November 2011
Size : 64 kB
Everolimus pro forma October 2011
Title : Everolimus pro forma October 2011
Size : 63 kB
Fulvestrant 3rd-4th line mBC November 2011
Title : Fulvestrant 3rd-4th line mBC November 2011
Size : 67 kB
Lapatinib 3rd line pro forma October 2011
Title : Lapatinib 3rd line pro forma October 2011
Size : 67 kB
Lenalidomide myeloma October 2011
Title : Lenalidomide myeloma October 2011
Size : 69 kB
Mifamurtide osteosarcoma October 2011
Title : Mifamurtide osteosarcoma October 2011
Size : 63 kB
Nilotinib CML November 2011
Title : Nilotinib CML November 2011
Size : 62 kB
Pazopanib metastatic renal October 2011
Title : Pazopanib metastatic renal October 2011
Size : 63 kB
Pemetrexed 2nd line NSCLC November 2011
Title : Pemetrexed 2nd line NSCLC November 2011
Size : 67 kB
Plerixafor myeloma October 2011
Title : Plerixafor myeloma October 2011
Size : 67 kB
Rituximab low grade B cell lymphoma October 2011
Title : Rituximab low grade B cell lymphoma October 2011
Size : 66 kB
Rituximab maintenance October 2011
Title : Rituximab maintenance October 2011
Size : 63 kB
Sorafenib pro forma October 2011
Title : Sorafenib pro forma October 2011
Size : 66 kB
Sunitinib metPNET November 2011
Title : Sunitinib metPNET November 2011
Size : 67 kB
Trabectedin Liposomal doxorubicin ovarian October 2011
Title : Trabectedin Liposomal doxorubicin ovarian October 2011
Size : 66 kB
Yttrium October 2011
Title : Yttrium October 2011
Size : 63 kB

Last modified on Wednesday 8th February, 2012 at 3:58pm.